A couple of years ago, in honor of Prostate Cancer Awareness Month, we invited Dr. James M. Fitzgerald to join us for a Q&A session to discuss prostate health and prostate cancer. We recently asked him to revisit his interview and provide info on the upcoming ZERO Prostate Cancer Run/Walk on Sunday, September 9.
But first, a quick anatomy refresher: The prostate is a small gland (think walnut sized) located in the male pelvis beneath the bladder and surrounding the urethra (the tube through which urine passes from the bladder out of the body). The prostate plays an important role in reproduction since it produces fluid that mixes with and protects sperm.
As men age, the prostate increases in size (this is known as benign prostatic hyperplasia, or BPH) and often causes urinary symptoms (slow urine stream, frequent urination, awakening during the night to urinate, etc.). The risk for prostate cancer also increases as men get older.
Now, let's turn to Dr. Fitzgerald.
As with all content on Greater Boston Urology's blog, the following information is educational in nature, not medical advice. Always talk to your physician about your specific health care questions and conditions.
[Editor's note: This article was reviewed and updated on 5/18/21 with additional links and media.]
DR. FITZGERALD: Unfortunately, prostate cancer is still a devastating disease that will affect 1 in 9 American men in their lifetime. It's the second leading cause of cancer death among men, resulting in a little more than 80 deaths per day.
In May 2018, the U.S. Preventive Services Task Force released its final recommendations regarding prostate cancer screening, and we believe the Task Force missed the mark. You can read Dr. Michael J. Curran's response, which reflects my own.
Bottom line: early detection saves lives.
At GBU, we follow the American Urologic Association (AUA) Guidelines, which support screening in men between the ages of 55-69 and earlier than age 55 for men who are known to be at increased risk for prostate cancer. This includes men with a family history of prostate cancer and African American men who should be screened as early as age 40.
Some men over age 70 may benefit from prostate cancer screening if they are in excellent health with a life expectancy of more than 10 years. These men should discuss testing with their physician.
Again, even though prostate cancer testing has come under scrutiny, we feel that screening in properly selected patients is appropriate and indicated. It is important that men make an informed decision about prostate cancer screening by discussing it with their doctor.
DR. FITZGERALD: If screening for prostate cancer reveals an elevated PSA or a nodule during a digital rectal exam, then the next step is a discussion between the urologist and patient about the options.
Typically, a transrectal ultrasound (TRUS) is performed to take pictures of the prostate and to provide guidance for biopsies of the prostate. Usually a biopsy sampling is done throughout the prostate with a total of 12 biopsies taken.
This is the test most commonly performed for initial evaluation of patients with an elevated PSA or a prostate nodule felt on exam. Patients who have had prior TRUS prostate biopsies and have a PSA that is continuing to increase (as well as those men with prostate cancer on active surveillance) are candidates for a relatively newer technique using 3D MRI/ultrasound fusion biopsy technology, which is discussed in another article on our website.
SpaceOAR is a valuable new tool for us to improve prostate cancer radiation treatment. If you're in the Greater Boston area, you're considering radiation treatment, and you would like to learn more, you can contact me at our North Easton Care Center or Dr. Stephen Craig Gillard in our Plymouth Care Center.
[Editor's note: Below is a video that explains SpaceOAR in more detail.]
DR. FITZGERALD: It is my hope that men—and those who love them—will understand the scope and severity of prostate cancer. There has been some controversy and public misperception that prostate cancer is "not serious." Although men diagnosed with prostate cancer very late in life are unlikely to die of their disease, prostate cancer in many men is a very serious problem in this country and worldwide.
Therefore, I would like men to understand the following:
Thanks, Dr. Fitzgerald!
Click here to schedule an appointment with Dr. Fitzgerald or one of our other urologists.